LINC00189: A Potential Drug Target and Biomarker (G193629)

Target Name: LINC00189

NCBI ID: G193629

LINC00189

Other Name(s): C21orf109 | Long intergenic non-protein coding RNA 189 | long intergenic non-protein coding RNA 189 | NCRNA00189

LINC00189: A Potential Drug Target and Biomarker

LINC00189 is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. The gene is located on chromosome 6 and encodes for a protein known as LINC00189, which is a scaffold protein that is involved in the regulation of cellular processes such as cell adhesion, migration, and survival.

LINC00189 has been shown to be involved in the development and progression of various diseases, including cancer. For example, studies have shown that high levels of LINC00189 are associated with poor prognosis in patients with pancreatic cancer, and that inhibiting LINC00189 may be a promising strategy for treating this disease.

In addition to its potential as a drug target, LINC00189 has also been identified as a potential biomarker for several diseases. For example, studies have shown that LINC00189 is expressed in the brains of individuals with Alzheimer's disease, and that levels of LINC00189 have been associated with the severity of cognitive impairment in these individuals. Additionally, LINC00189 has been shown to be involved in the regulation of immune responses, and may be a potential biomarker for autoimmune diseases such as rheumatoid arthritis and multiple sclerosis.

The potential utility of LINC00189 as a drug target and biomarker makes it an attractive target for researchers to investigate further. Researchers are currently working to develop small molecules that can inhibit LINC00189 and are exploring these compounds as potential new treatments for a variety of diseases.

In conclusion, LINC00189 is a gene that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand its role in these processes and to develop new treatments based on LINC00189 inhibitors.

Protein Name: Long Intergenic Non-protein Coding RNA 189

The "LINC00189 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00189 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets